EBIT (Quarterly)

EBIT: Income before interest and taxes.

PTC Therapeutics, Inc. (PTCT) had EBIT of $-71.35M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$164.68M
Net Income	$-134.97M
Cost of Goods Sold	$6.95M
Gross Profit	$157.73M
Operating Expenses	$236.03M
Operating Income	$-71.35M
Non-Operating Income/Expense	$-67.73M
Pre-Tax Income	$-139.08M
Normalized Pre-Tax Income	$-139.08M
Income after Taxes	$-134.97M
Income from Continuous Operations	$-134.97M
Consolidated Net Income/Loss	$-134.97M
Normalized Income after Taxes	$-134.97M
EBIT	$-71.35M
EBITDA	$-63.18M
Weighted-Average Shares Outstanding (Basic)	79.53M
Weighted-Average Shares Outstanding (Diluted)	88.31M
Earnings per Share (EPS) (Basic)	$-1.88
Earnings per Share (EPS) (Diluted)	$-1.63
Balance Sheet Financials
Current Assets	$2.27B
Property, Plant, and Equipment	$55.37M
Long-Term Assets	$624.82M
Total Assets	$2.90B
Current Liabilities	$968.43M
Long-Term Debt	$2.03B
Long-Term Liabilities	$2.14B
Total Liabilities	$3.10B
Common Equity	$-205.31M
Tangible Shareholders Equity	$-676.41M
Shareholders Equity	$-205.31M
Common Shares Outstanding	81.47M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$711.20M
Cash Flow from Investing Activities	$-861.98M
Cash Flow from Financial Activities	$331.09M
Beginning Cash	$795.32M
End Cash	$998.33M
Increase/Decrease in Cash	$203.02M
Stock-Based Compensation	$74.55M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.35
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.11
Debt to Equity Ratio	-12.67
Gross Margin	95.78%
Operating Margin	-43.33%
EBIT Margin	-43.33%
EBITDA Margin	--
Pre-Tax Profit Margin	-84.46%
Profit Margin	-81.96%
Free Cash Flow	$702.41M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.06
Inventory Turnover	0.09
Receiveable Turnover	0.91
Days Sales in Receivables	99.26
Return on Equity	65.74%
Return on Tangible Equity	19.95%
Return on Assets	-4.66%
Return on Investments	-7.40%
Book Value Per Share	$-2.52
Free Cash Flow per Share	$7.95
Operating Cash Flow per Share	$8.05

Data from Zacks Investment Research, Inc.